Search

Your search keyword '"Brucker, Sara Y."' showing total 1,137 results

Search Constraints

Start Over You searched for: Author "Brucker, Sara Y." Remove constraint Author: "Brucker, Sara Y." Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
1,137 results on '"Brucker, Sara Y."'

Search Results

2. Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations

3. Radiotherapy statements of the 18th St. Gallen International Breast Cancer Consensus Conference—a German expert perspective

4. The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype

6. Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer

8. Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival

9. CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

12. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

13. Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole

17. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

18. Gemeinsames Positionspapier der onkologisch tätigen Fachgesellschaften der AWMF Ad hoc Kommission Versorgungsstrukturen zu der „Dritten Stellungnahme und Empfehlung der Regierungskommission für eine moderne und bedarfsgerechte Krankenhausversorgung mit grundlegender Reform der Krankenhausvergütung“

19. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

20. Adressen

21. Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association ConsortiumBreast Cancer Risk Factors and Survival By Tumor Subtype

22. Return of individual genomic research results within the PRAEGNANT multicenter registry study

25. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

27. Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041)

28. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.

29. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

30. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

31. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

35. Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study

37. CDK4/6 Inhibition – Therapy Sequences and the Quest to Find the Best Biomarkers – an Overview of Current Programs

38. Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry

39. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis.

40. Genome-wide association study of germline variants and breast cancer-specific mortality.

41. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

43. Long-Term Follow-Up Regarding Pain Relief, Fertility, and Re-Operation after Surgery for Deep Endometriosis.

44. Predictive Clinical Decision Support System with RNN Encoding and Tensor Decoding

45. Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.

46. L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile

47. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

48. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.

49. Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

50. Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Catalog

Books, media, physical & digital resources